B87.8 Myiasis of other sites

Name of the Condition

• Myiasis of other sites

Summary

Myiasis of other sites is a parasitic infestation involving live fly larvae (maggots) in body regions outside the skin or wounds. The condition occurs when flies deposit eggs or larvae on non-cutaneous or non-wound sites, which then hatch and feed on the host's tissue. It may affect areas such as the gastrointestinal tract, genitourinary system, or other internal structures, with severity varying by fly species and host factors.

Causes

Myiasis of other sites is caused by the larvae of certain fly species, which deposit eggs or larvae on specific body sites. The larvae hatch and feed on the host's tissue, leading to infestation. Transmission typically occurs through contact with contaminated environments, animals, or flies, with larvae targeting sites like mucous membranes or internal cavities.

Risk Factors

• Poor hygiene or inadequate sanitation.
• Living in or traveling to regions with high fly populations.
• Underlying anatomical or physiological conditions that expose internal sites.
• Prolonged exposure to environments with decaying organic matter.
• Immunocompromised states or pre-existing tissue abnormalities.

Symptoms

• Crawling or moving sensations in the affected area.
• Visible larvae or maggots in non-skin/non-wound sites (e.g., orifices, cavities).
• Localized pain, irritation, or discomfort at the infested site.
• Swelling, redness, or discharge from the affected region.
• Systemic symptoms (e.g., fever, nausea) in severe or invasive cases.

Diagnosis

Diagnosis is primarily clinical, based on the presence of larvae in non-skin/non-wound sites. Healthcare providers may examine the affected area, review patient history (e.g., exposure to flies or contaminated environments), and use imaging or endoscopic procedures to confirm infestation in internal sites.

Treatment Options

Treatment involves mechanical removal of larvae, often with irrigation or extraction. Topical or systemic agents (e.g., antiparasitics) may be used to eliminate remaining larvae. Wound care and infection prevention are critical, with antibiotics prescribed if secondary bacterial infection is present. Follow-up ensures complete resolution and monitors for recurrence.

Prognosis and Follow-Up

Prognosis is generally favorable with prompt treatment, though severe infestations (e.g., internal sites) may require extended care. Follow-up appointments assess healing, check for residual larvae, and address any complications. Immunocompromised patients or those with extensive infestations may need closer monitoring.

Complications

• Secondary bacterial infections at the infested site.
• Tissue damage from larval feeding.
• Systemic reactions (e.g., fever, allergic responses).
• Delayed healing or chronic infestation if untreated.

Lifestyle & Prevention

• Maintain good hygiene and sanitation practices.
• Avoid exposure to areas with high fly activity or decaying matter.
• Protect open orifices (e.g., with clean dressings) in high-risk environments.
• Use insect repellents or barriers when in endemic regions.
• Seek prompt care for wounds or tissue abnormalities to reduce infestation risk.

When to Seek Professional Help

Consult a healthcare provider if you experience crawling sensations, visible larvae, or unexplained pain in non-skin/non-wound sites, especially after exposure to flies or contaminated environments. Seek immediate care for systemic symptoms (e.g., fever, severe pain) or signs of infection.

Tips for Medical Coders

Document the specific site of myiasis (e.g., gastrointestinal, genitourinary) and any associated complications. Ensure clinical notes support the diagnosis and site involvement. Code B87.8 is assigned when the infestation occurs in sites other than skin or wounds, with specificity to the affected area documented.